David Malcolm Crowe

Title: The Innovations of David Malcolm Crowe

Introduction

David Malcolm Crowe is a notable inventor based in Tonbridge, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory compounds. With a total of 2 patents, Crowe's work has had a meaningful impact on medical science.

Latest Patents

One of Crowe's latest patents is for "Crystalline complexes of fluticasone-2-furoate." This patent describes a crystalline complex that stabilizes a compound of formula (I) through the presence of a guest molecule. The crystalline complex is characterized by its space group P222, with unit cell dimensions of about 12.5±1.0 Å, 15±1.0 Å, and 16.2±1.0 Å when determined at either 120K or 150K. Another significant patent is for "Anti-inflammatory androstane derivative compositions," which further showcases his expertise in creating effective pharmaceutical formulations.

Career Highlights

Throughout his career, Crowe has worked with prominent companies in the pharmaceutical industry, including Glaxo Group Limited and SmithKline Beecham Corporation. His experience in these organizations has allowed him to refine his skills and contribute to innovative projects that address critical health issues.

Collaborations

Crowe has collaborated with several professionals in his field, including Keith Biggadike and Steven John Coote. These partnerships have facilitated the exchange of ideas and have led to advancements in their respective areas of expertise.

Conclusion

David Malcolm Crowe's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to inspire advancements in medical science and improve patient care.